Gene Expression of Angiotensin-Converting Enzyme 2 Receptor in Skin and the Implications for COVID-19

被引:11
|
作者
Al-Benna, Sammy [1 ,2 ]
机构
[1] Stellenbosch Univ, Div Plast & Reconstruct Surg, Med & Hlth Sci, Cape Town, South Africa
[2] Tygerberg Acad Hosp, Cape Town, South Africa
关键词
angiotensin-converting enzyme 2; coronavirus; COVID-19; lungs; receptor; severe acute respiratory syndrome; skin;
D O I
10.1097/01.ASW.0000722748.73437.7d
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
BACKGROUND: Binding to the angiotensin-converting enzyme 2 (ACE2) receptor is a critical step for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) to enter target cells. This enzyme is expressed in many human tissues including the lungs, but no research has demonstrated that SARS-CoV-2 can infect human skin or subcutaneous fat tissue, despite the increasing number of reported skin manifestations. The aim of this study was to investigate ACE2 gene expression in skin using a public database. METHODS: A search of transcriptomic data sets from a public gene expression database to investigate ACE2 gene expression in human tissues. RESULTS: Human skin keratinocytes and basal cells express more ACE2 than lung epithelial cells. In contrast, both fibroblasts and melanocytes from human skin express less ACE2 than human lung epithelial cells. CONCLUSIONS: The high expression of ACE2 in keratinocytes and basal cells of human skin indicates that they may be directly susceptible to SARS-CoV-2 infection via the ACE2 receptor, especially in conditions of skin barrier dysfunction, and are therefore a potential target for the coronavirus.
引用
收藏
页码:31 / 35
页数:5
相关论文
共 50 条
  • [41] Theoretical Assessment of Therapeutic Effects of Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors on COVID-19
    Khalili, Azadeh
    Karim, Hosein
    Bayat, Gholamreza
    IRANIAN JOURNAL OF MEDICAL SCIENCES, 2021, 46 (04) : 312 - 316
  • [42] Association of Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker Use With COVID-19 Diagnosis and Mortality
    Fosbol, Emil L.
    Butt, Jawad H.
    ostergaard, Lauge
    Andersson, Charlotte
    Selmer, Christian
    Kragholm, Kristian
    Schou, Morten
    Phelps, Matthew
    Gislason, Gunnar H.
    Gerds, Thomas A.
    Torp-Pedersen, Christian
    Kober, Lars
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (02): : 168 - 177
  • [43] Angiotensin-Converting Enzyme Inhibitors, Angiotensin II Receptor Blockers, and Outcomes in Patients Hospitalized for COVID-19
    Pan, Michael
    Vasbinder, Alexi
    Anderson, Elizabeth
    Catalan, Toniemarie
    Shadid, Husam R.
    Berlin, Hanna
    Padalia, Kishan
    O'Hayer, Patrick
    Meloche, Chelsea
    Azam, Tariq U.
    Khaleel, Ibrahim
    Michaud, Erinleigh
    Blakely, Pennelope
    Bitar, Abbas
    Huang, Yiyuan
    Zhao, Lili
    Pop-Busui, Rodica
    Loosen, Sven H.
    Chalkias, Athanasios
    Tacke, Frank
    Giamarellos-Bourboulis, Evangelos J.
    Reiser, Jochen
    Eugen-Olsen, Jesper
    Hayek, Salim S.
    JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2021, 10 (24):
  • [44] Angiotensin-converting enzyme 2 decreased expression during kidney inflammatory diseases: implications to predisposing to COVID-19 kidney complications
    Garcia, Gabriela E.
    Truong, Luan D.
    Johnson, Richard J.
    KIDNEY INTERNATIONAL, 2021, 100 (05) : 1138 - 1140
  • [45] Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
    Kuba, Keiji
    Yamaguchi, Tomokazu
    Penninger, Josef M.
    FRONTIERS IN IMMUNOLOGY, 2021, 12
  • [46] The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection
    Kaseb, Ahmed O.
    Mohamed, Yehia, I
    Malek, Alexandre E.
    Raad, Issam I.
    Altameemi, Lina
    Li, Dan
    Kaseb, Omar A.
    Kaseb, Safa A.
    Selim, Abdelhafez
    Ma, Qing
    PATHOGENS, 2021, 10 (03):
  • [47] COVID-19 and angiotensin-converting enzyme inhibitors from plant origin
    Gharebaghi, Reza
    Heidary, Fatemeh
    JOURNAL OF INTEGRATIVE MEDICINE-JIM, 2022, 20 (05):
  • [48] COVID-19 and angiotensin-converting enzyme inhibitors from plant origin
    Reza Gharebaghi
    Fatemeh Heidary
    Journal of Integrative Medicine, 2022, 20 (05) : 476 - 476
  • [49] Angiotensin-Converting Enzyme 2 Gene Expression in Breast Tissue
    Al-Benna, Sammy
    EUROPEAN JOURNAL OF BREAST HEALTH, 2021, 17 (02) : 112 - 115
  • [50] COVID-19 and the use of angiotensin-converting enzyme inhibitors and receptor blockers. Scientific brief
    不详
    PEDIATRIA I MEDYCYNA RODZINNA-PAEDIATRICS AND FAMILY MEDICINE, 2020, 16 (01): : 120 - 121